Literature DB >> 9664577

Genomic polymorphism among Blastocystis hominis strains and development of subtype-specific diagnostic primers.

H Yoshikawa1, I Nagano, Z Wu, E H Yap, M Singh, Y Takahashi.   

Abstract

Genomic polymorphisms among nine strains of Blastocystis hominis were examined by random amplified polymorphic DNA (RAPD) using four different arbitrary polymerase chain reaction (PCR) primers. Based on the RAPD patterns, nine strains were classified into three groups. The specific primers designed from the unique bands yielded a single band from within each same group, but did not amplify between all the groups examined. Specificity of these diagnostic primers was tested against several common intestinal parasites and a yeast, and no amplification was confirmed. Since the current criteria indicates that Blastocystis organisms isolated from humans are designated as B. hominis, the authors propose to classify several subtypes among B. hominis groups based on the difference of genomic DNA using three diagnostic primers.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9664577     DOI: 10.1006/mcpr.1998.0161

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  31 in total

1.  Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis.

Authors:  Javed Yakoob; Wasim Jafri; Mohammad Asim Beg; Zaigham Abbas; Shagufta Naz; Muhammad Islam; Rustam Khan
Journal:  Parasitol Res       Date:  2010-02-23       Impact factor: 2.289

2.  High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain).

Authors:  M Victoria Domínguez-Márquez; Remedios Guna; Carlos Muñoz; M Teresa Gómez-Muñoz; Rafael Borrás
Journal:  Parasitol Res       Date:  2009-05-27       Impact factor: 2.289

3.  Genetic variability of Blastocystis hominis isolates in China.

Authors:  Yiming Yan; Shuilian Su; Riyong Lai; Hua Liao; Jinhua Ye; Xiaobo Li; Xiaoting Luo; Guifeng Chen
Journal:  Parasitol Res       Date:  2006-05-11       Impact factor: 2.289

4.  Genomic analysis of Blastocystis hominis strains isolated from two long-term health care facilities.

Authors:  H Yoshikawa; N Abe; M Iwasawa; S Kitano; I Nagano; Z Wu; Y Takahashi
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  Infectivity of Blastocystis isolates from chickens, quails and geese in chickens.

Authors:  Aya Tanizaki; Hisao Yoshikawa; Satoru Iwatani; Isao Kimata
Journal:  Parasitol Res       Date:  2005-03-17       Impact factor: 2.289

6.  Fecal-oral transmission of the cyst form of Blastocystis hominis in rats.

Authors:  Hisao Yoshikawa; Kumi Yoshida; Ayumi Nakajima; Kimie Yamanari; Satoru Iwatani; Isao Kimata
Journal:  Parasitol Res       Date:  2004-10-09       Impact factor: 2.289

7.  Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries.

Authors:  Hisao Yoshikawa; Zhiliang Wu; Isao Kimata; Motohiro Iseki; Ibne Karim M D Ali; Momammad B Hossain; Viqar Zaman; Rashidul Haque; Yuzo Takahashi
Journal:  Parasitol Res       Date:  2003-11-04       Impact factor: 2.289

8.  Molecular epidemiology of human Blastocystis isolates in France.

Authors:  Laetitia Souppart; Giovanna Sanciu; Amandine Cian; Ivan Wawrzyniak; Frederic Delbac; Monique Capron; Eduardo Dei-Cas; Kenneth Boorom; Laurence Delhaes; Eric Viscogliosi
Journal:  Parasitol Res       Date:  2009-03-17       Impact factor: 2.289

9.  Subtype identification of Blastocystis spp. isolated from patients in a major hospital in northeastern Thailand.

Authors:  Sarinee Jantermtor; Porntip Pinlaor; Kookwan Sawadpanich; Somchai Pinlaor; Arunnee Sangka; Chotechana Wilailuckana; Wachanan Wongsena; Hisao Yoshikawa
Journal:  Parasitol Res       Date:  2012-12-09       Impact factor: 2.289

Review 10.  New insights on classification, identification, and clinical relevance of Blastocystis spp.

Authors:  Kevin S W Tan
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.